Straumann Holding Past Earnings Performance
We're still processing the latest earnings report of this company
Past criteria checks 1/6
Straumann Holding has been growing earnings at an average annual rate of 7.4%, while the Medical Equipment industry saw earnings growing at 7.4% annually. Revenues have been growing at an average rate of 8.5% per year. Straumann Holding's return on equity is 16.5%, and it has net margins of 13.7%.
Key information
7.44%
Earnings growth rate
7.38%
EPS growth rate
| Medical Equipment Industry Growth | 11.07% |
| Revenue growth rate | 8.52% |
| Return on equity | 16.54% |
| Net Margin | 13.69% |
| Next Earnings Update | 19 Aug 2026 |
Recent past performance updates
Recent updates
Narrative Update • Jun 06
STMN: Rich Multiples And Execution Risks Will Likely Cap Future Returns
Straumann Holding's analyst price target has been nudged higher by CHF 1, as analysts highlight updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E, supported by recent incremental target increases from major banks. Analyst Commentary Recent research has focused on how fair value assumptions for Straumann Holding align with current market pricing, with some analysts trimming their estimates even as others make small upward adjustments to price targets.Narrative Update • May 22
STMN: Cautious CHF 81 Fair Value Will Likely Limit Near-Term Upside
The updated analyst price target for Straumann has been revised slightly higher to CHF 81.17 from CHF 80.00, as analysts factor in updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E following recent Street research updates. Analyst Commentary Recent Street research on Straumann Holding has included both higher and lower price targets, with some bearish analysts highlighting execution and valuation risks even as others adjust targets higher.
Narrative Update • May 01
STMN: Higher Future P/E Assumptions Will Support Confidence In Execution Potential
Straumann's updated analyst price target holds around CHF 123, with recent small CHF 1 to CHF 3 adjustments from different banks reflecting analysts' mixed views on future growth, profit margins, and the appropriate P/E level for the shares. Analyst Commentary Recent Street research shows a mix of views on Straumann, with price targets clustering around CHF 79 to CHF 123 and opinions split on whether the current P/E is justified.Narrative Update • Apr 16
STMN: Lower-End CHF 80 Fair Value Will Likely Cap Upside Potential
The updated analyst price target for Straumann Holding edges higher to CHF 80, a CHF 1 change that reflects recent Street research in which analysts have fine tuned assumptions on discount rates, revenue growth and profit margins while incorporating mixed price target moves across firms. Analyst Commentary Recent Street research on Straumann Holding highlights a split in sentiment, with some firms trimming price targets while others make smaller upward adjustments.Narrative Update • Apr 02
STMN: Higher Revenue Assumptions Will Support Confidence In Future Execution Potential
Narrative update on Straumann Holding The updated analyst price target for Straumann Holding moves to CHF 123 from CHF 145, reflecting recent cuts to Street targets, including reductions from Citi, JPMorgan, Morgan Stanley and Deutsche Bank, as analysts factor in revised assumptions for discount rates, growth, margins and future P/E multiples. Analyst Commentary Recent Street research on Straumann Holding shows a wide range of views, with price targets spanning from CHF 79 to CHF 123 and ratings from Sell to Buy.Narrative Update • Mar 18
STMN: Higher P/E And Dividend Support Will Likely Anchor Balanced Risk Reward
The updated analyst price target for Straumann Holding has been revised to CHF 79 from CHF 84. This change reflects analysts' adjustments to fair value, discount rate, revenue growth, profit margin and future P/E assumptions following a series of recent target cuts across several banks.
Narrative Update • Mar 04
STMN: Future Margin Delivery And Uplifted Growth Assumptions Support Renewed Optimism
The analyst price target for Straumann has been reduced by about CHF 3 to reflect slightly higher discount assumptions, a lower fair value estimate of about CHF 107.78 versus CHF 111.22, and mixed Street targets ranging from CHF 79 to CHF 123, even as analysts factor in updated views on growth, margins and future P/E. Analyst Commentary Recent Street research on Straumann Holding reflects a split view on upside potential and execution risk, with price targets clustering between CHF 79 and CHF 123 and ratings ranging from Underweight to Buy and Overweight.Narrative Update • Feb 17
STMN: Elevated P/E And Tight Execution Room Will Likely Cap Future Upside
Analysts have raised their price target for Straumann Holding by CHF 3, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E that are generally consistent with recent mixed target moves from firms such as Citi and Deutsche Bank. Analyst Commentary Recent Street research around Straumann Holding has been mixed, with some firms adjusting price targets in different directions.Narrative Update • Feb 03
STMN: Elevated P/E Will Likely Expose Limited Upside From Current Levels
Analysts have adjusted their price targets for Straumann, with recent Street research pointing to mixed views on valuation. Updated assumptions around a fair value of about CHF 80.80, revenue growth of 7.59%, a profit margin of 21.02% and a future P/E of 21.74x help frame the revised outlook.Analysis Article • Jan 28
Straumann Holding (VTX:STMN) Could Become A Multi-Bagger
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Narrative Update • Jan 19
STMN: Improving U.S. Execution And Orthodontics Partnerships Will Support Renewed Optimism
Straumann Holding's analyst fair value estimate has edged down by roughly CHF 1 to about CHF 111, as analysts balance slightly softer margin and P/E assumptions with mixed recent Street price target revisions and generally improved sentiment since the Q3 report. Analyst Commentary Recent Street research around Straumann has turned more mixed, with some bullish analysts leaning into improving sentiment after the Q3 report, while more cautious voices focus on valuation risk and execution consistency.Narrative Update • Jan 05
STMN: Improving U.S. Execution And Orthodontics Partnerships Will Likely Drive Renewed Optimism
Straumann Holding's updated analyst price target has edged down by about CHF 0.50 to CHF 111.74, as analysts factor in slightly lower fair value, revenue growth, and margin assumptions while balancing mixed Street research that ranges from reduced targets and downgrades to upgrades highlighting improving U.S. operational momentum and fewer perceived negative catalysts. Analyst Commentary Recent Street research on Straumann highlights a split view, with some analysts becoming more comfortable with the risk reward while others stay cautious on growth and margins.Analysis Article • Dec 29
What Does Straumann Holding AG's (VTX:STMN) Share Price Indicate?
Straumann Holding AG ( VTX:STMN ) received a lot of attention from a substantial price movement on the SWX over the...Narrative Update • Dec 16
STMN: Improving U.S. Momentum Will Likely Drive Renewed Optimism And Upside
The analyst price target for Straumann Holding has been modestly increased to CHF 112.24 from CHF 112.43, as analysts factor in improving investor sentiment, gradually better operational momentum in the U.S., and a slightly higher future earnings multiple despite trimmed growth and margin expectations. Analyst Commentary Recent research updates on Straumann Holding present a mixed but gradually improving picture, with several bullish analysts highlighting better sentiment and operational progress, while more cautious voices point to lingering earnings and valuation risks.Narrative Update • Dec 02
STMN: Improving U.S. Momentum Will Drive Renewed Optimism And Share Upside
Straumann Holding’s analyst price target has been lifted modestly to CHF 112.43 from CHF 111.61, as analysts reflect improved U.S. operational momentum and a recent shift in sentiment following the company’s quarterly report. Analyst Commentary Recent street research reflects a dynamic range of viewpoints on Straumann Holding, as analysts weigh evolving sentiment and operational signals primarily from the U.S. market.Narrative Update • Nov 18
STMN: Gradually Improving U.S. Operational Momentum Will Support Renewed Share Performance
Straumann Holding’s analyst price target saw a modest increase, rising from CHF 111.29 to CHF 111.61. Analysts point to improved investor sentiment and gradual operational momentum reflected in recent research updates.Narrative Update • Nov 03
STMN: Future Performance Will Depend On U S Operational Recovery And Margin Stability
Straumann Holding's analyst price target saw a modest decrease to CHF 111.29 from CHF 111.58, as analysts weighed improving U.S. operational trends in contrast with ongoing concerns over slower revenue growth and margin adjustments. Analyst Commentary Analysts remain divided on the outlook for Straumann Holding, highlighting both areas of growing confidence and lingering concerns regarding the company's performance and prospects.Narrative Update • Oct 20
Asia-Pacific And Latin America Will Transform Digital Dentistry
Straumann Holding's analyst price target has been reduced from CHF 116.45 to CHF 111.58, as analysts lower growth expectations in response to a slower than anticipated U.S. recovery and revised margin outlooks. Analyst Commentary Recent analyst revisions reflect a mix of optimism about Straumann Holding's strategic positioning and caution regarding its near-term growth outlook.Narrative Update • Oct 05
Asia-Pacific And Latin America Will Transform Digital Dentistry
Straumann Holding's analyst price target was recently reduced from CHF 118.65 to CHF 116.45. Analysts cite slightly softer revenue growth projections and ongoing revisions from major investment banks as reasons for the adjustment.Narrative Update • Sep 19
Asia-Pacific And Latin America Will Transform Digital Dentistry
Despite concerns over slower near-term growth, macroeconomic uncertainty, and margin pressures, analysts remain confident in Straumann’s long-term fundamentals—driven by its innovation pipeline and global reach—resulting in a modest upward revision of the consensus price target from CHF117.00 to CHF118.65. Analyst Commentary Bearish analysts cite softer short-term growth expectations and macroeconomic uncertainty impacting demand for dental implants.Narrative Update • Sep 04
Asia-Pacific And Latin America Will Transform Digital Dentistry
Straumann Holding’s consensus price target was reiterated at CHF117.00 as analysts balanced concerns about margin pressure, slower growth, and macroeconomic risks with confidence in the company’s long-term strategy and innovation. Analyst Commentary Bearish analysts cite ongoing margin pressure and weaker-than-expected profitability as headwinds for Straumann.Analysis Article • Aug 06
Many Would Be Envious Of Straumann Holding's (VTX:STMN) Excellent Returns On Capital
There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...Analysis Article • Jul 14
Is There Now An Opportunity In Straumann Holding AG (VTX:STMN)?
Straumann Holding AG ( VTX:STMN ) saw a double-digit share price rise of over 10% in the past couple of months on the...
New Narrative • Nov 07
Revolutionary Digital Solutions And Global Expansion Drive SIRIOS Growth Forward
Launching innovative digital solutions and products is expected to drive revenue growth, enhance customer retention, and strengthen market position.Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How Straumann Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 25 | 2,605 | 357 | 1,183 | 0 |
| 30 Sep 25 | 2,592 | 392 | 1,187 | 0 |
| 30 Jun 25 | 2,579 | 428 | 1,216 | 0 |
| 31 Mar 25 | 2,541 | 443 | 1,197 | 0 |
| 31 Dec 24 | 2,504 | 458 | 1,153 | 0 |
| 30 Sep 24 | 2,455 | 474 | 1,132 | 0 |
| 30 Jun 24 | 2,406 | 490 | 1,111 | 0 |
| 31 Mar 24 | 2,341 | 469 | 1,088 | 0 |
| 31 Dec 23 | 2,277 | 448 | 1,065 | 0 |
| 30 Sep 23 | 2,282 | 421 | 1,120 | 0 |
| 30 Jun 23 | 2,286 | 394 | 1,175 | 0 |
| 31 Mar 23 | 2,304 | 415 | 1,194 | 0 |
| 31 Dec 22 | 2,321 | 435 | 1,212 | 0 |
| 30 Sep 22 | 2,268 | 462 | 1,157 | 0 |
| 30 Jun 22 | 2,215 | 489 | 1,102 | 0 |
| 31 Mar 22 | 2,118 | 442 | 1,053 | 0 |
| 31 Dec 21 | 2,022 | 396 | 1,004 | 0 |
| 30 Sep 21 | 1,914 | 377 | 929 | 0 |
| 30 Jun 21 | 1,806 | 358 | 855 | 0 |
| 31 Mar 21 | 1,616 | 224 | 793 | 0 |
| 31 Dec 20 | 1,426 | 91 | 731 | 0 |
| 30 Sep 20 | 1,424 | 79 | 741 | 0 |
| 30 Jun 20 | 1,421 | 67 | 751 | 0 |
| 31 Mar 20 | 1,509 | 187 | 776 | 0 |
| 31 Dec 19 | 1,596 | 306 | 801 | 0 |
| 30 Sep 19 | 1,529 | 298 | 769 | 0 |
| 30 Jun 19 | 1,462 | 289 | 737 | 0 |
| 31 Mar 19 | 1,413 | 281 | 708 | 0 |
| 31 Dec 18 | 1,364 | 273 | 680 | 0 |
| 30 Sep 18 | 1,307 | 271 | 652 | 0 |
| 30 Jun 18 | 1,250 | 269 | 624 | 0 |
| 31 Mar 18 | 1,181 | 274 | 592 | 0 |
| 31 Dec 17 | 1,112 | 280 | 561 | 0 |
| 30 Sep 17 | 1,056 | 257 | 544 | 0 |
| 30 Jun 17 | 1,000 | 235 | 528 | 0 |
| 31 Mar 17 | 959 | 232 | 511 | 0 |
| 31 Dec 16 | 918 | 230 | 494 | 0 |
| 30 Sep 16 | 889 | 218 | 483 | 0 |
| 30 Jun 16 | 861 | 207 | 473 | 0 |
| 31 Mar 16 | 830 | 139 | 459 | 0 |
| 31 Dec 15 | 799 | 71 | 445 | 0 |
| 30 Sep 15 | 774 | 79 | 434 | 0 |
| 30 Jun 15 | 750 | 88 | 423 | 0 |
Quality Earnings: STMN has a large one-off loss of CHF136.0M impacting its last 12 months of financial results to 31st December, 2025.
Growing Profit Margin: STMN's current net profit margins (13.7%) are lower than last year (18.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: STMN's earnings have grown by 7.4% per year over the past 5 years.
Accelerating Growth: STMN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: STMN had negative earnings growth (-22.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (-6.9%).
Return on Equity
High ROE: STMN's Return on Equity (16.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/16 18:11 |
| End of Day Share Price | 2026/06/16 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Straumann Holding AG is covered by 34 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Bate | Barclays |
| Hassan Al-Wakeel | Barclays |
| Victoria Lambert | Berenberg |